Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.2 (
alanine aminotransferase
)
26,722
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present study aims to investigate the protective effects of
Dendrobine
and its underlying mechanisms on liver injury induced by isoniazid (INH) and rifampicin (RIF). A mouse model of liver injury was induced by intragastrically administration of 100 mg/kg INH and 100 mg/kg RIF for 14 days. The mice were intragastrically administrated with
Dendrobine
(50, 100, and 200 mg/kg) before the administration of INH and RIF. Serum
alanine aminotransferase
(
ALT
) and aspartate aminotransferase (AST) were determined. Oxidative stress markers including glutathione, superoxide dismutase, and malondialdehyde in the liver were measured and liver histopathological examinations were performed. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot were applied to determine the mRNA and protein expressions, respectively. Luciferase reporter assay was used to evaluate the interactions between miR-295-5p and CYP1A2.
Dendrobine
significantly decreased serum
ALT
and AST and inhibited the liver index and ameliorated the liver histological changes induced by INH and RIF. Besides,
Dendrobine
also regulated oxidative stress status in the liver by the regulation of CYP1A2. Moreover, mmu-miR-295-5p was identified to target CYP1A2 and to regulate the expression of CYP1A2. In summary,
Dendrobine
ameliorated INH and RIF induced mouse liver injury by miR-295-5p-mediated CYP1A2 expression.
...
PMID:Dendrobine attenuates isoniazid- and rifampicin-induced liver injury by inhibiting miR-295-5p. 3263 53